Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,836 | 7,375 | 11,569 | 5,811 | 1,876 |
| Receivables | 198 | 176 | 322 | N/A | 12 |
| TOTAL | $4,751 | $8,242 | $13,044 | $7,093 | $3,613 |
| Non-Current Assets | |||||
| PPE Net | 20 | 25 | 38 | 52 | 61 |
| Investments And Advances | 0 | 0 | 112 | 112 | 112 |
| Other Non-Current Assets | 456 | 0 | 0 | 38 | 150 |
| TOTAL | $476 | $25 | $150 | $201 | $324 |
| Total Assets | $5,227 | $8,266 | $13,194 | $7,295 | $3,936 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,968 | 1,565 | 2,510 | 2,708 | 2,132 |
| TOTAL | $2,968 | $1,565 | $2,510 | $2,772 | $2,284 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 0 | N/A | 0 | 25 | N/A |
| Other Non-Current Liabilities | 833 | 554 | 392 | 6,541 | 0 |
| TOTAL | $833 | $554 | $392 | $6,541 | $N/A |
| Total Liabilities | $3,801 | $2,119 | $2,902 | $9,313 | $2,284 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 917 | 834 | 833 | 833 | 19 |
| Common Shares | 0 | 0 | 2 | 0 | 2 |
| Retained earnings | -84,420 | -79,564 | -75,287 | -63,202 | -57,255 |
| TOTAL | $1,426 | $6,148 | $10,293 | $-2,019 | $1,652 |
| Total Liabilities And Equity | $5,227 | $8,266 | $13,194 | $7,295 | $3,936 |